======= EIF3H ======= == Gene Information == * **Official Symbol**: EIF3H * **Official Name**: eukaryotic translation initiation factor 3 subunit H * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8667|8667]] * **UniProt**: [[https://www.uniprot.org/uniprot/O15372|O15372]] * **Interactions**: [[https://thebiogrid.org/search.php?search=EIF3H&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EIF3H|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603912|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre- initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:17581632). The eIF- 3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). {ECO:0000255|HAMAP-Rule:MF_03007, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}. |Mov34| |eukaryotic translation initiation factor 3 complex, eIF3m| |eukaryotic 48S preinitiation complex| |eukaryotic translation initiation factor 3 complex| |formation of cytoplasmic translation initiation complex| |eukaryotic 43S preinitiation complex| |cytoplasmic translational initiation| |polysomal ribosome| |translation initiation factor activity| |metallopeptidase activity| |cytoplasmic translation| |regulation of translational initiation| |translational initiation| |ribonucleoprotein complex assembly| |ribonucleoprotein complex subunit organization| |regulation of translation| |translation| |regulation of cellular amide metabolic process| |peptide biosynthetic process| |ribonucleoprotein complex biogenesis| |posttranscriptional regulation of gene expression| |amide biosynthetic process| |peptide metabolic process| |cellular amide metabolic process| |cellular protein-containing complex assembly| |proteolysis| |RNA binding| |organonitrogen compound biosynthetic process| |protein-containing complex assembly| |cellular nitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |protein-containing complex subunit organization| |membrane| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|-3.14| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|-2.44| |[[:results:exp539|42°C R08 exp539]]|-2.13| |[[:results:exp82|Torin1 0.08μM R02 exp82]]|-1.72| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|1.76| |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|1.78| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|1.78| |[[:results:exp314|Dimethyloxaloylglycine 11μM R07 exp314]]|1.8| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|1.82| |[[:results:exp58|UM131593 0.1μM R01 exp58]]|1.88| |[[:results:exp116|AICAR 240μM R03 exp116]]|1.95| |[[:results:exp275|Citral 75μM R06 exp275]]|1.96| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|2.04| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|2.05| |[[:results:exp274|Citral 50μM R06 exp274]]|2.31| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|2.31| |[[:results:exp534|Trientine 500μM R08 exp534]]|2.42| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|2.48| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|2.62| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|2.78| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|3.1| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|3.34| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|3.99| |[[:results:exp264|Arsenate 40μM R06 exp264]]|4.14| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.502| Global Fraction of Cell Lines Where Essential: 286/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|8/28| |blood|6/28| |bone|12/26| |breast|11/33| |central nervous system|30/56| |cervix|1/4| |colorectal|8/17| |esophagus|2/13| |fibroblast|1/1| |gastric|5/16| |kidney|4/21| |liver|10/20| |lung|27/75| |lymphocyte|6/16| |ovary|9/26| |pancreas|9/24| |peripheral nervous system|14/16| |plasma cell|5/15| |prostate|1/1| |skin|13/24| |soft tissue|3/9| |thyroid|0/2| |upper aerodigestive|3/22| |urinary tract|9/29| |uterus|2/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2226 * **Expression level (log2 read counts)**: 7.4 {{:chemogenomics:nalm6 dist.png?nolink |}}